Contact
Please use this form to send email to PR contact of this press release:
BioAge Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures – Hagens Berman
TO:
Please use this form to send email to PR contact of this press release:
BioAge Labs (BIOA) Azelaprag Trial Halt Raises Questions About Pre-IPO Disclosures – Hagens Berman
TO: